Latent reservoirs of HIV infection: Flushing with IL-2?
David A. Cooper
& Sean Emery
National Centre in HIV Epidemiology and Clinical Research,
Faculty of Medicine, University of New South Wales Sydney
NSW 2052, Australia dcooper@nchecr.unsw.edu.au
A new study suggests it may be possible to further dilute quantities of
infectious HIV in infected people by combining potent anti-retroviral therapy
with immune therapy using interleukin-2 (pages 651−655).
